Studies: Zoledronat bei KnochenmetastasenID TrialCZOL446EDE15Clinicaltrials.gov identifierNCT00172003DescriptionEffect of i.v. zoledronate 4 mg on bone metastasis in patients with renal cell carcinoma. A prospective study. StatusclosedDisease
SponsorNovartisRoonstr. 25 90429 Nürnberg Germany Coordinating investigatorNo dataPrincipal investigator
Study nurseNo data |
|